|
|
|
The following experts are members of the company’s medical/scientific advisory board.
|
 |
Professor John A. Hunt
John (D.Sc., Ph.D.) is Reader in Tissue Engineering, and Head of the Division of Clinical Engineering (UK Centre for Tissue Engineering (UKCTE). He has worked in this field of research for the past 20 years, with more than 90 peer-reviewed scientific publications, and obtained his D.Sc. on the basis of significant published research in the field of Biomaterials and Tissue Engineering entitled “Cell Material Homeostasis” in 2006. He serves as Associate Editor for the journal Biomaterials, Subject Editor for Biomaterials in “Current Opinion in Solid State and Materials Science”, and on the editorial board of the International Journal of Adipose Tissue (IJAT). He is a committee member on the board of the Royal Society of Chemistry, Analytical Biosciences Group. As acting Head of the Division of Clinical Engineering he leads a research group of 20 staff and students.
|
|
Comprised mainly of academic staff, Ph.D., and post-doctoral students, the group presented 10 papers at the 2008 World Biomaterials congress in Amsterdam and 14 papers at the European Chapter meeting of Tissue Engineering (TERMIS) in Porto. The group's research focuses on the assessment of the cellular and molecular mechanisms of biocompatibility and tissue engineering, addressing the key areas of primary cell sourcing, controlling cell function and phenotype by substrate interactions, angiogenesis and inflammation. As an applied science it is important to learn from and encourage other disciplines into the subject. The research is global and encompasses both industrial and academic partners. In Europe, Clinical Engineering acts as the Scientific Co-ordinator of STEPS, an Integrated Programme of research in Framework VI with 23 European partners to take a systems approach to Tissue Engineering. John also serves as a member of the project review panels for national research funding bodies and councils in Ireland, France, Switzerland, Singapore, and the UK, as well as providing independent peer review for many charities and other funding bodies.
|
Professor Eric Masterson
Orthopaedic Surgeon
Eric is a Consultant Orthopedic Surgeon in practice at the Midwestern Regional Hospital in Limerick and at the Regional Orthopedic Hospital in Croom, Co. Limerick. He is also Adjunct Professor of Orthopaedic Science at the University of Limerick Medical School. He graduated from University College Dublin in 1984 and after going through the Senior Registrar Program spent two years in Canada working on fellowships in Adult Reconstruction and Musculoskeletal Oncology before returning to Ireland to take up the post in Limerick. He has published extensively in peer-reviewed Journals. Eric is on the editorial board of a number of Orthopaedic journals including The Journal of Bone and Joint Surgery. He has an extensive clinical practice in the area of primary and revision hip and knee arthroplasty and musculoskeletal oncology.
|
|
|
Professor Brian Meenan
Brian holds the Chair of Biomedical Materials at the University of Ulster and is Head of the Biomaterials and Tissue Engineering Research Group within the Nanotechnology and Advanced Materials Research Institute (NAMRI). He is also Director of the University of Ulster Hub of the EPSRC funded Innovation Manufacturing Research Centre (IMRC) MATCH (Multidisciplinary Assessment of Technology Centre for Healthcare) and is a Principle Investigator in the EPSRC Grand Challenge Initiative, Regenerative Medicine: A New Industry (Remedi). He is also a lead scientist within NANOTEC Northern Ireland which is an EU funded regional Centre of Excellence established as a collaboration between the University of Ulster, Queen's University, Belfast and Invest Northern Ireland (INI). Brian has an extensive record of peer-reviewed publications and research grant income and has active collaborations within the UK, Europe, the U.S., and Asia.
|
|
He is a Past President of the UK Society for Biomaterials (UKSB) and immediate past Chairman of the Royal Society of Chemistry Northern Ireland Section. He is currently a member of the Institute for Materials, Minerals and Mining (IoMMM) Biomedical Materials Applications Division Committee, the Royal Society if Chemistry Biomaterials Chemistry Interest Group Committee and is currently a member of the EPSRC Peer Review College. Brian's research interests are directed toward the development of advanced biomaterials for medical device applications with particular emphasis on promoting interactions on the sub-micron to nanometer scale for applications in tissue engineering and regenerative medicine. Core projects include studies of bioactive surfaces and reactions thereon; calcium phosphate thin film coatings; modification of polymer surfaces by atmospheric dielectric barrier discharge (DBD); control and medication of cell-surface interactions and the development of new methods for in situ biological process control in a bioreactor environment. Much recent emphasis has focused on the role of nanotechnology for enhancement of in vivo functionality of biomaterials and medicine. Professor Meenan also has extensive experience of surface analytical techniques for biomaterial/medical device characterization.
|
Professor David C. Greenspan
David is a leader in the field of implantable bioactive materials with over 32 years of experience in the medical device industry. He has extensive experience in the development of medical devices, taking products from concept to market. His experience spans design control; regulatory processes and strategies (FDA, EU, and Health Canada); project management; and marketing. His educational background is in the physics and chemistry of glasses, materials science, biomaterials, and in business management. David has served as Product Development Manager, Vice President Product Development, Vice President Global R&D, and Chief Scientific Officer among other job functions. He holds more than 30 U.S. and international patents in various technology areas including medical devices, wound care, oral care consumer products, and industrial systems. David has published more than 35 peer-reviewed articles and presented at more than 60 international conferences in the area of medical devices. David is also active in the American Society for Testing and Materials (ASTM). As a member of Committee F-4, he was responsible for drafting Standards and was a delegate to ISO committees drafting 10993 documents. David serves on a number of university external advisory boards. He is also a member of the Orthopaedic Research Society, Society for Biomaterials, ASTM, and the International Association for Dental Research.
|
|
|
Professor Warren Grundfest
Warren is currently Professor of Biomedical Engineering, Electrical Engineering, and Surgery at the University of California, Los Angeles. He received his MD degree from Columbia University, College of Physicians and Surgeons, in 1980 and trained in General Surgery at UCLA and Cedars-Sinai Medical Center. He was appointed Assistant Director of Surgery and Assistant Clinical Professor of Surgery at UCLA in 1987. In 1995 he was appointed Research Professor of Biomedical Engineering at University of Southern California and as Visiting Associate in Mechanical Engineering at California Institute of Technology (Caltech). Warren served as Director of the Cedars-Sinai Laser Research and Technology Development Program from 1989-2001, holding the Dorothy and E. Philip Lyon Chair in Laser Research. Warren served as Chair of the UCLA Biomedical Engineering Program from 1999-2002.
|
|
Warren developed microendoscopy as a tool for the study of acute coronary ischemic syndromes, and pioneered the development of minimally invasive techniques for the treatment of cardiovascular disease. He has designed, built, and tested multiple new lasers, optical diagnostic instruments, and minimally invasive surgical tools to reduce the need for invasive surgery. In 1994 he was inducted into the Space Technology Hall of Fame for his use of NASA laser technology for cardiovascular applications. In 1996 he was elected Fellow, American Institute of Medical and Biologic Engineers (AIMBE), for pioneering development and dissemination of minimally invasive surgery. In the same year he was elected Fellow, Society of Photo-Optical Instrumentation Engineers (SPIE), for his distinguished and valuable contributions to the field of optical engineering in medicine and biology. Dr. Grundfest is a past member of the Surgery and Bioengineering Study Section of the National Institutes of Health Center for Scientific Review, has chaired multiple review panels, and regularly consults for the NIH and FDA. He works closely with the UCLA CASIT (Center for Advanced Surgical and Interventional Technologies) in the development of haptic feedback systems, optical sensors, and robotic systems to improve the capabilities of minimally invasive surgery. Warren currently serves as a Senior Technology Advisor to TATRC (Telemedicine and Technology Research Center of the Army).
|
|
